and consultancy/advisory board work for Boehringer Ingelheim, consultancy for Genentech, Regeneron and GlaxoSmithKline, consultancy/data monitoring committee work for PulmonX, advisory board work for ModoSpira and Toshiba, grants from and consultancy for Janssen Pharmaceuticals, outside the submitted work; is founder and co-owner of Quantitative Imaging Solutions; and G.R Washko's spouse works for Biogen, which is focused on developing therapies for fibrotic lung disease. B.A. Raby reports grants from National Institutes of Health (P01HL114501), during the conduct of the study. I.O. Rosas reports grants from National Institutes of Health (P01HL114501), during the conduct of the study.